The general mortality trends in DCM has shown a decreasing trend over the years, primarily due to the advanced heart failure therapies including MCS and HT in drug-refractory cases.
← all excerpts
National Trends in Admissions, Treatments, and Outcomes for Dilated Cardiomyopathy (2016-2021).
1
—
—